Type 1 Diabetes (T1D) Clinical Trials in Chicago, Illinois
4 studies are recruiting for type 1 diabetes (t1d) in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tolerability, and efficacy of OPF-310 transplantation and to define the recommended Phase 2 dose (RP2D) in adult subjects with unstable Type 1 D…
- Stage
- Phase 1
- Ages
- 35 to 70
- Site
- University of Illinois Hospital & Health Sciences System, Chicago, Illinois
- Run by
- Otsuka Pharmaceutical Factory, Inc.
-
Circadian Mechanisms, Glucose, and CV Risks in T1D
People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improvin…
- Stage
- Not phased
- Ages
- 18 to 50
- Site
- University of Illinois Chicago, Chicago, Illinois
- Run by
- University of Illinois at Chicago
-
Kidney Precision Medicine Project
Acute kidney injury (AKI) and chronic kidney disease (CKD) impose a significant global health burden. Yet, no effective therapies currently exist for AKI, and only a few are available for CKD. Despite significant effort from industry and academia, development of pharmacologic therapies for AKI and …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Illinois Chicago, Chicago, Illinois
- Locations
- 13 in total
- Run by
- Icahn School of Medicine at Mount Sinai
-
Type 1 Diabetes and Obstructive Sleep Apnea
The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.
- Stage
- Not phased
- Ages
- 18 to 50
- Site
- University of Chicago, Chicago, Illinois
- Run by
- University of Chicago
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.